Table 1 Individual demographic and clinical information
From: Single-cell analysis of immune cell transcriptome during HIV-1 infection and therapy
Sample ID | Sample group | Gender | Race/ethnicity | Age | Viral load | CD4 count | ART |
|---|---|---|---|---|---|---|---|
0036 | HIV-1 seronegative | Male | Ngoni | 45 | NA | 713 | NA |
1363 | HIV-1 seronegative | Male | Chewa | 34 | NA | 615 | NA |
1628 | HIV-1 seronegative | Male | Lomwe | 26 | NA | 908 | NA |
0501 | HIV-1 untreated | Male | Black/African American | 37 | 15,651 | 514 | NA |
0010 | HIV-1 untreated | Male | Tumbuka | 25 | 436,975 | 317 | NA |
0468 | HIV-1 untreated | Male | Chewa | 27 | 101,634 | 300 | NA |
0694 | HIV-1 untreated | Female | Lomwe | 26 |  > 750,000 | 301 | NA |
0782 | HIV-1 untreated | Male | Xhosa | 30 | 18,169 | 389 | NA |
0391 | HIV-1 untreated | Female | Xhosa | 26 |  > 750,000 | 236 | NA |
0592 | HIV-1 ART treated | Male | Black/African American | 24 |  < 400 | 566 | Atripla (243 days) |
0010 | HIV-1 ART treated | Male | Tumbuka | 25 |  < 400 | 243 | Triomune (243 days) |
0694 | HIV-1 ART treated | Female | Lomwe | 26 |  < 400 | 493 | Triomune (191 days) |